Олеся Алексеевна Стативко
City Clinical Hospital · 55 works · 14 citations · h-index 2
Top works
- Maintenance Therapy With Avelumab for Patients With Metastatic Urothelial Carcinoma: A Real‐World, Ambispective RAVE ‐Bladder Study
- First results of a multicenter, non-randomized, prospective phase II study of the efficacy and safety of induction therapy with pembrolizumab, cisplatin, and 5-fluorouracil in patients with unresectable squamous cell carcinoma of the oropharynx, hypopharynx and larynx
- Toxicity and Safety of Induction Chemotherapy in Locally Advanced Oropharynx, Hypopharynx and Larynx: Non-Randomized Study Comparing DCF and Immunochemotherapy (ICT) with PF-Pembrolizumab
- Comparative analysis of induction chemotherapy followed by chemoradiotherapy and concurrent chemoradiation therapy efficacy in patients with locally advanced head and neck squamous cell cancer
- Comparative analysis of efficacy and safety of combined immunotherapy and immune targeted therapy in the first-line treatment of advanced renal cell carcinoma: a real-world study
- Efficacy of the combination of lenvatinib with pembrolizumab in patients with advanced renal cell carcinoma
- Maintenance therapy with avelumab as the first-line treatment in patients with metastatic urothelial carcinoma: A real-world, ambispective RAVE-Bladder study.
- 284P Real-world efficacy of lenvatinib and pembrolizumab as first-line therapy in patients with metastatic renal cell carcinoma with high burden disease
- 56P Palbociclib versus ribociclib in first-line therapy of patients with metastatic breast cancer: Direct comparison in real-world practice
- Single-center, non-randomized, prospective phase II study evaluating the effectiveness of induction chemoimmunotherapy in the combined outcome of locally advanced non-small cell lung disease
- Первые результаты многоцентрового нерандомизированного проспективного исследования II фазы изучения эффективности и безопасности индукционной терапии пембролизумабом, цисплатином и 5-фторурацилом у пациентов с нерезектабельным плоскоклеточным раком ротоглотки, гортаноглотки и гортани
- Безопасность и токсичность комбинированной терапии 1-й линии у больных распространенным почечно-клеточным раком: исследование реальной клинической практики
- Empegfilgrastim for primary febrile neutropenia prophylaxis during induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in head and neck squamous cell carcinoma.
- Biomarkers of resistance to anti-EGFR therapy in patients with left-sided colorectal cancer: a retrospective NGS analysis
- Комбинация ленватиниба и пембролизумаба в качестве первой линии терапии распространенного рака эндометрия: клинический случай
- Predictive role of peripheral blood erythroblasts for treatment intensification in metastatic hormone-sensitive prostate cancer. A retrospective study
- Lenvatinib in combination with pembrolizumab as first-line therapy for advanced endometrial cancer: clinical case
- Adjuvant abemaciclib in pN2-3 patients with HR+/HER2− early breast cancer: Real-world outcomes from Moscow centers.
- Predictive value of genomic mutation signatures and tumor mutational burden for induction immunochemotherapy in locally advanced squamous cell carcinoma of the oropharynx, larynx, and hypopharynx.
- 575eP The role of peripheral blood erythroblasts in patients with metastatic hormone receptor-positive HER2-negative breast cancer